Preconditioning provides neuroprotection in models of CNS disease: Paradigms and clinical significance

Progress in Neurobiology

Volumn 114, Issue , 2014, Pages 58-83

  Stetler, R Anne ^a,b,d   Leak, Rehana K ^c   Gan, Yu ^a,b   Li, Peiying ^a,b   Zhang, Feng ^a,b,d   Hu, Xiaoming ^b,d   Jing, Zheng ^b,d   Chen, Jun ^a,b,d   Zigmond, Michael J ^a,b   Gao, Yanqin ^a  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c DUQUESNE UNIVERSITY   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Ischemia; Neuroprotection; Preconditioning; Traumatic brain injury

Indexed keywords

ALCOHOL; ANALGESIC AGENT; ANESTHETIC AGENT; NEUROTOXIN;

BRAIN INJURY; CALORIC RESTRICTION; CENTRAL NERVOUS SYSTEM DISEASE; CONDITIONING; CROSS TOLERANCE; DEFENSE MECHANISM; DEGENERATIVE DISEASE; EXERCISE; HUMAN; HYPERBARIC OXYGEN; HYPERTHERMIA; HYPOTHERMIA; HYPOXIA; INFLAMMATION; ISCHEMIC PRECONDITIONING; METABOLIC INHIBITION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; TEMPERATURE; TRAUMATIC BRAIN INJURY;

ISCHEMIA; NEUROPROTECTION; PRECONDITIONING; TRAUMATIC BRAIN INJURY;

ANIMALS; CENTRAL NERVOUS SYSTEM DISEASES; DISEASE MODELS, ANIMAL; HUMANS; ISCHEMIC PRECONDITIONING; NEUROPROTECTIVE AGENTS;

EID: 84896400147     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2013.11.005     Document Type: Review

References (415)

1. Abekawa T., Ohmori T., Koyama T. Tolerance to the neurotoxic effect of methamphetamine in rats behaviorally sensitized to methamphetamine or amphetamine. Brain Res. 1997, 767:34-44.
2. Adamczyk S., Robin E., Simerabet M., Kipnis E., Tavernier B., Vallet B., Bordet R., Lebuffe G. Sevoflurane pre- and post-conditioning protect the brain via the mitochondrial K ATP channel. Br. J. Anaesth. 2010, 104:191-200.
3. Al-Jarrah M., Jamous M., Al Zailaey K., Bweir S.O. Endurance exercise training promotes angiogenesis in the brain of chronic/progressive mouse model of Parkinson's Disease. NeuroRehabilitation 2010, 26:369-373.
4. Albert-Weissenberger C., Siren A.L. Experimental traumatic brain injury. Exp. Transl. Stroke Med. 2010, 2:16.
5. Alex J., Laden G., Cale A.R., Bennett S., Flowers K., Madden L., Gardiner E., McCollum P.T., Griffin S.C. Pretreatment with hyperbaric oxygen and its effect on neuropsychometric dysfunction and systemic inflammatory response after cardiopulmonary bypass: a prospective randomized double-blind trial. J. Thorac. Cardiovasc. Surg. 2005, 130:1623-1630.
6. Allam M.F., Campbell M.J., Hofman A., Del Castillo A.S., Fernandez-Crehuet Navajas R. Smoking and Parkinson's disease: systematic review of prospective studies. Mov. Disord. 2004, 19:614-621.
7. Allen N.E., Canning C.G., Sherrington C., Lord S.R., Latt M.D., Close J.C., O'Rourke S.D., Murray S.M., Fung V.S. The effects of an exercise program on fall risk factors in people with Parkinson's disease: a randomized controlled trial. Mov. Disord. 2010, 25:1217-1225.
8. Apostolakis E., Baikoussis N.G., Papakonstantinou N.A. The role of myocardial ischaemic preconditioning during beating heart surgery: biological aspect and clinical outcome. Interact. Cardiovasc. Thorac. Surg. 2012, 14:68-71.
9. Appelros P., Stegmayr B., Terent A. Sex differences in stroke epidemiology: a systematic review. Stroke 2009, 40:1082-1090.
10. Ara J., De Montpellier S. Hypoxic-preconditioning enhances the regenerative capacity of neural stem/progenitors in subventricular zone of newborn piglet brain. Stem Cell Res. 2013, 11:669-686.
11. Archer T., Fredriksson A., Johansson B. Exercise alleviates Parkinsonism: clinical and laboratory evidence. Acta Neurol. Scand. 2011, 123:73-84.
12. Arthur P.G., Lim S.C., Meloni B.P., Munns S.E., Chan A., Knuckey N.W. The protective effect of hypoxic preconditioning on cortical neuronal cultures is associated with increases in the activity of several antioxidant enzymes. Brain Res. 2004, 1017:146-154.
13. Arumugam T.V., Gleichmann M., Tang S.C., Mattson M.P. Hormesis/preconditioning mechanisms, the nervous system and aging. Ageing Res. Rev. 2006, 5:165-178.
14. Azmoon S., Demarest C., Pucillo A.L., Hjemdahl-Monsen C., Kay R., Ahmadi N., Aronow W.S., Frishman W.H. Neurologic and cardiac benefits of therapeutic hypothermia. Cardiol. Rev. 2011, 19:108-114.
15. Baron J.A. Cigarette smoking and Parkinson's disease. Neurology 1986, 36:1490-1496.
16. Barone F.C., Feuerstein G.Z. Inflammatory mediators and stroke: new opportunities for novel therapeutics. J. Cereb. Blood Flow Metab. 1999, 19:819-834.
17. Barone, F.C., White, R.F., Spera, P.A., Ellison, J., Currie, R.W., Wang, X., Feuerstein, G.Z., 1998. Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. Stroke 29, 1937-1950 (discussion 1950-1931).
18. Bastide M., Gele P., Petrault O., Pu Q., Caliez A., Robin E., Deplanque D., Duriez P., Bordet R. Delayed cerebrovascular protective effect of lipopolysaccharide in parallel to brain ischemic tolerance. J. Cereb. Blood Flow Metab. 2003, 23:399-405.
19. Belmadani A., Kumar S., Schipma M., Collins M.A., Neafsey E.J. Inhibition of amyloid-beta-induced neurotoxicity and apoptosis by moderate ethanol preconditioning. Neuroreport 2004, 15:2093-2096.
20. 2+-mediated neurotoxicity. Neuroscience 2001, 104:769-781.
21. Berger K., Ajani U.A., Kase C.S., Gaziano J.M., Buring J.E., Glynn R.J., Hennekens C.H. Light-to-moderate alcohol consumption and risk of stroke among U.S. male physicians. N. Engl. J. Med. 1999, 341:1557-1564.
22. Bernard S. Hypothermia after cardiac arrest: expanding the therapeutic scope. Crit. Care Med. 2009, 37:S227-S233.
23. Bernaudin M., Nedelec A.S., Divoux D., MacKenzie E.T., Petit E., Schumann-Bard P. Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J. Cereb. Blood Flow Metab. 2002, 22:393-403.
24. Bickler P.E., Fahlman C.S. Expression of signal transduction genes differs after hypoxic or isoflurane preconditioning of rat hippocampal slice cultures. Anesthesiology 2009, 111:258-266.
25. Bickler P.E., Fahlman C.S., Gray J., McKleroy W. Inositol 1,4,5-triphosphate receptors and NAD(P)H mediate Ca2+ signaling required for hypoxic preconditioning of hippocampal neurons. Neuroscience 2009, 160:51-60.
26. Bickler P.E., Fahlman C.S., Gray J.J. Hypoxic preconditioning failure in aging hippocampal neurons: impaired gene expression and rescue with intracellular calcium chelation. J. Neurosci. Res. 2010, 88:3520-3529.
27. 2+ and mitogen-activated protein kinase signaling. Anesthesiology 2005, 103:532-539.
28. Billard J.M., Rouaud E. Deficit of NMDA receptor activation in CA1 hippocampal area of aged rats is rescued by d-cycloserine. Eur. J. Neurosci. 2007, 25:2260-2268.
29. Bingham D., John C.M., Levin J., Panter S.S., Jarvis G.A. Post-injury conditioning with lipopolysaccharide or lipooligosaccharide reduces inflammation in the brain. J. Neuroimmunol. 2013, 256:28-37.
30. Bordet R., Deplanque D., Maboudou P., Puisieux F., Pu Q., Robin E., Martin A., Bastide M., Leys D., Lhermitte M., Dupuis B. Increase in endogenous brain superoxide dismutase as a potential mechanism of lipopolysaccharide-induced brain ischemic tolerance. J. Cereb. Blood Flow Metab. 2000, 20:1190-1196.
31. Bowman C.C., Rasley A., Tranguch S.L., Marriott I. Cultured astrocytes express toll-like receptors for bacterial products. Glia 2003, 43:281-291.
32. Braak H., Del Tredici K. Neuroanatomy and pathology of sporadic Parkinson's disease. Adv. Anat. Embryol. Cell Biol. 2009, 201:1-119.
33. Bradford S.T., Stamatovic S.M., Dondeti R.S., Keep R.F., Andjelkovic A.V. Nicotine aggravates the brain postischemic inflammatory response. Am. J. Physiol. Heart Circ. Physiol. 2011, 300:H1518-H1529.
34. Brandt M.D., Maass A., Kempermann G., Storch A. Physical exercise increases Notch activity, proliferation and cell cycle exit of type-3 progenitor cells in adult hippocampal neurogenesis. Eur. J. Neurosci. 2010, 32:1256-1264.
35. Bronner G., Mitchell K., Welsh F.A. Cerebrovascular adaptation after unilateral carotid artery ligation in the rat: preservation of blood flow and ATP during forebrain ischemia. J. Cereb. Blood Flow Metab. 1998, 18:118-121.
36. Brouillet E., Jacquard C., Bizat N., Blum D. 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease. J. Neurochem. 2005, 95:1521-1540.
37. Bruer U., Weih M.K., Isaev N.K., Meisel A., Ruscher K., Bergk A., Trendelenburg G., Wiegand F., Victorov I.V., Dirnagl U. Induction of tolerance in rat cortical neurons: hypoxic preconditioning. FEBS Lett. 1997, 414:117-121.
38. Bsibsi M., Ravid R., Gveric D., van Noort J.M. Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 2002, 61:1013-1021.
39. Burda J., Danielisova V., Nemethova M., Gottlieb M., Matiasova M., Domorakova I., Mechirova E., Ferikova M., Salinas M., Burda R. Delayed postconditionig initiates additive mechanism necessary for survival of selectively vulnerable neurons after transient ischemia in rat brain. Cell. Mol. Neurobiol. 2006, 26:1141-1151.
40. Cadet J.L., McCoy M.T., Cai N.S., Krasnova I.N., Ladenheim B., Beauvais G., Wilson N., Wood W., Becker K.G., Hodges A.B. Methamphetamine preconditioning alters midbrain transcriptional responses to methamphetamine-induced injury in the rat striatum. PLoS ONE 2009, 4:e7812.
41. Cannon J.R., Hua Y., Richardson R.J., Xi G., Keep R.F., Schallert T. The effect of thrombin on a 6-hydroxydopamine model of Parkinson's disease depends on timing. Behav. Brain Res. 2007, 183:161-168.
42. Cannon J.R., Keep R.F., Hua Y., Richardson R.J., Schallert T., Xi G. Thrombin preconditioning provides protection in a 6-hydroxydopamine Parkinson's disease model. Neurosci. Lett. 2005, 373:189-194.
43. Cardenas A., Moro M.A., Leza J.C., O'Shea E., Davalos A., Castillo J., Lorenzo P., Lizasoain I. Upregulation of TACE/ADAM17 after ischemic preconditioning is involved in brain tolerance. J. Cereb. Blood Flow Metab. 2002, 22:1297-1302.
44. Carreno-Muller E., Herrera A.J., de Pablos R.M., Tomas-Camardiel M., Venero J.L., Cano J., Machado A. Thrombin induces in vivo degeneration of nigral dopaminergic neurones along with the activation of microglia. J. Neurochem. 2003, 84:1201-1214.
45. Carvey P.M., Chang Q., Lipton J.W., Ling Z. Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: a potential, new model of Parkinson's disease. Front. Biosci. 2003, 8:s826-s837.
46. Caso J.R., Pradillo J.M., Hurtado O., Lorenzo P., Moro M.A., Lizasoain I. Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation 2007, 115:1599-1608.
47. Cebere A., Liljequist S. Ethanol differentially inhibits homoquinolinic acid- and NMDA-induced neurotoxicity in primary cultures of cerebellar granule cells. Neurochem. Res. 2003, 28:1193-1199.
48. Cernak I. Animal models of head trauma. NeuroRx 2005, 2:410-422.
49. Cerqueira F.M., Cunha F.M., Laurindo F.R., Kowaltowski A.J. Calorie restriction increases cerebral mitochondrial respiratory capacity in a NO*mediated mechanism: impact on neuronal survival. Free Radic. Biol. Med. 2012, 52:1236-1241.
50. Chan M.T., Boet R., Ng S.C., Poon W.S., Gin T. Effect of ischemic preconditioning on brain tissue gases and pH during temporary cerebral artery occlusion. Acta Neurochir. Suppl. 2005, 95:93-96.
51. Chandler L.J., Sumners C., Crews F.T. Ethanol inhibits NMDA receptor-mediated excitotoxicity in rat primary neuronal cultures. Alcohol. Clin. Exp. Res. 1993, 17:54-60.
52. Chang C.P., Chio C.C., Cheong C.U., Chao C.M., Cheng B.C., Lin M.T. Hypoxic preconditioning enhances the therapeutic potential of the secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury. Clin. Sci. (Lond.) 2013, 124:165-176.
53. Chen H., Zhang S.M., Schwarzschild M.A., Hernan M.A., Ascherio A. Physical activity and the risk of Parkinson disease. Neurology 2005, 64:664-669.
54. Chen T., Kato H., Liu X.H., Araki T., Itoyama Y., Kogure K. Ischemic tolerance can be induced repeatedly in the gerbil hippocampal neurons. Neurosci. Lett. 1994, 177:159-161.
55. Chen Y., Nie H., Tian L., Tong L., Yang L., Lao N., Dong H., Sang H., Xiong L. Nicotine-induced neuroprotection against ischemic injury involves activation of endocannabinoid system in rats. Neurochem. Res. 2013, 38:364-370.
56. Cheng O., Ostrowski R.P., Wu B., Liu W., Chen C., Zhang J.H. Cyclooxygenase-2 mediates hyperbaric oxygen preconditioning in the rat model of transient global cerebral ischemia. Stroke 2011, 42:484-490.
57. Choi D.Y., Liu M., Hunter R.L., Cass W.A., Pandya J.D., Sullivan P.G., Shin E.J., Kim H.C., Gash D.M., Bing G. Striatal neuroinflammation promotes Parkinsonism in rats. PLoS ONE 2009, 4:e5482.
58. Choi S.H., Joe E.H., Kim S.U., Jin B.K. Thrombin-induced microglial activation produces degeneration of nigral dopaminergic neurons in vivo. J. Neurosci. 2003, 23:5877-5886.
59. Chuang T.J., Lin K.C., Chio C.C., Wang C.C., Chang C.P., Kuo J.R. Effects of secretome obtained from normoxia-preconditioned human mesenchymal stem cells in traumatic brain injury rats. J. Trauma Acute Care Surg. 2012, 73:1161-1167.
60. Codaccioni J.L., Velly L.J., Moubarik C., Bruder N.J., Pisano P.S., Guillet B.A. Sevoflurane preconditioning against focal cerebral ischemia: inhibition of apoptosis in the face of transient improvement of neurological outcome. Anesthesiology 2009, 110:1271-1278.
61. Collins M.A., Neafsey E.J., Mukamal K.J., Gray M.O., Parks D.A., Das D.K., Korthuis R.J. Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies. Alcohol. Clin. Exp. Res. 2009, 33:206-219.
62. Collins M.A., Neafsey E.J., Wang K., Achille N.J., Mitchell R.M., Sivaswamy S. Moderate ethanol preconditioning of rat brain cultures engenders neuroprotection against dementia-inducing neuroinflammatory proteins: possible signaling mechanisms. Mol. Neurobiol. 2010, 41:420-425.
63. Collins M.A., Neafsey E.J., Zou J.Y. HIV-I gpI20 neurotoxicity in brain cultures is prevented by moderate ethanol pretreatment. Neuroreport 2000, 11:1219-1222.
64. Corbett D., Giles T., Evans S., McLean J., Biernaskie J. Dynamic changes in CA1 dendritic spines associated with ischemic tolerance. Exp. Neurol. 2006, 202:133-138.
65. Costa T., Constantino L.C., Mendonca B.P., Pereira J.G., Herculano B., Tasca C.I., Boeck C.R. N-methyl-d-aspartate preconditioning improves short-term motor deficits outcome after mild traumatic brain injury in mice. J. Neurosci. Res. 2010, 88:1329-1337.
66. Coyle P., Panzenbeck M.J. Collateral development after carotid artery occlusion in Fischer 344 rats. Stroke 1990, 21:316-321.
67. Danaceau J.P., Deering C.E., Day J.E., Smeal S.J., Johnson-Davis K.L., Fleckenstein A.E., Wilkins D.G. Persistence of tolerance to methamphetamine-induced monoamine deficits. Eur. J. Pharmacol. 2007, 559:46-54.
68. Dave K.R., Saul I., Prado R., Busto R., Perez-Pinzon M.A. Remote organ ischemic preconditioning protect brain from ischemic damage following asphyxial cardiac arrest. Neurosci. Lett. 2006, 404:170-175.
69. Davis A.E., Campbell S.J., Wilainam P., Anthony D.C. Post-conditioning with lipopolysaccharide reduces the inflammatory infiltrate to the injured brain and spinal cord: a potential neuroprotective treatment. Eur. J. Neurosci. 2005, 22:2441-2450.
70. Dawson D.A., Furuya K., Gotoh J., Nakao Y., Hallenbeck J.M. Cerebrovascular hemodynamics and ischemic tolerance: lipopolysaccharide-induced resistance to focal cerebral ischemia is not due to changes in severity of the initial ischemic insult, but is associated with preservation of microvascular perfusion. J. Cereb. Blood Flow Metab. 1999, 19:616-623.
71. De Ley G., Nshimyumuremyi J.B., Leusen I. Hemispheric blood flow in the rat after unilateral common carotid occlusion: evolution with time. Stroke 1985, 16:69-73.
72. Della Morte D., Abete P., Gallucci F., Scaglione A., D'Ambrosio D., Gargiulo G., De Rosa G., Dave K.R., Lin H.W., Cacciatore F., Mazzella F., Uomo G., Rundek T., Perez-Pinzon M.A., Rengo F. Transient ischemic attack before nonlacunar ischemic stroke in the elderly. J. Stroke Cerebrovasc. Dis. 2008, 17:257-262.
73. Di Meo S., Venditti P. Mitochondria in exercise-induced oxidative stress. Biol. Signals Recept. 2001, 10:125-140.
74. Die J., Wang K., Fan L., Jiang Y., Shi Z. Rosuvastatin preconditioning provides neuroprotection against spinal cord ischemia in rats through modulating nitric oxide synthase expressions. Brain Res. 2010, 1346:251-261.
75. Ding Y., Li L. Lipopolysaccharide preconditioning induces protection against lipopolysaccharide-induced neurotoxicity in organotypic midbrain slice culture. Neurosci. Bull. 2008, 24:209-218.
76. Ding Y.H., Li J., Yao W.X., Rafols J.A., Clark J.C., Ding Y. Exercise preconditioning upregulates cerebral integrins and enhances cerebrovascular integrity in ischemic rats. Acta Neuropathol. 2006, 112:74-84.
77. Ding Y.H., Young C.N., Luan X., Li J., Rafols J.A., Clark J.C., McAllister 2nd J.P., Ding Y. Exercise preconditioning ameliorates inflammatory injury in ischemic rats during reperfusion. Acta Neuropathol. 2005, 109:237-246.
78. Dirnagl U., Iadecola C., Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999, 22:391-397.
79. Dirnagl U., Simon R.P., Hallenbeck J.M. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci. 2003, 26:248-254.
80. Domoki F., Kis B., Gaspar T., Snipes J.A., Parks J.S., Bari F., Busija D.W. Rosuvastatin induces delayed preconditioning against oxygen-glucose deprivation in cultured cortical neurons. Am. J. Physiol. Cell. Physiol. 2009, 296:C97-C105.
81. Duan W., Lee J., Guo Z., Mattson M.P. Dietary restriction stimulates BDNF production in the brain and thereby protects neurons against excitotoxic injury. J. Mol. Neurosci. 2001, 16:1-12.
82. Duan W., Mattson M.P. Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease. J. Neurosci. Res. 1999, 57:195-206.
83. Duan W., Ross C.A. Potential therapeutic targets for neurodegenerative diseases: lessons learned from calorie restriction. Curr. Drug Targets 2010, 11:1281-1292.
84. Ducroquet A., Leys D., Saabi A.A., Richard F., Cordonnier C., Girot M., Deplanque D., Casolla B., Allorge D., Bordet R. Influence of chronic ethanol consumption on the neurological severity in patients with acute cerebral ischemia. Stroke 2013, 44:2324-2326.
85. Duffy P.H., Feuers R., Nakamura K.D., Leakey J., Hart R.W. Effect of chronic caloric restriction on the synchronization of various physiological measures in old female Fischer 344 rats. Chronobiol. Int. 1990, 7:113-124.
86. Duffy P.H., Feuers R.J., Leakey J.A., Nakamura K., Turturro A., Hart R.W. Effect of chronic caloric restriction on physiological variables related to energy metabolism in the male Fischer 344 rat. Mech. Ageing Dev. 1989, 48:117-133.
87. Durukan A., Tatlisumak T. Preconditioning-induced ischemic tolerance: a window into endogenous gearing for cerebroprotection. Exp. Transl. Stroke Med. 2010, 2:2.
88. Eklind S., Mallard C., Arvidsson P., Hagberg H. Lipopolysaccharide induces both a primary and a secondary phase of sensitization in the developing rat brain. Pediatr. Res. 2005, 58:112-116.
89. El Amki M., Lerouet D., Coqueran B., Curis E., Orset C., Vivien D., Plotkine M., Marchand-Leroux C., Margaill I. Experimental modeling of recombinant tissue plasminogen activator effects after ischemic stroke. Exp. Neurol. 2012, 238:138-144.
90. El Ayadi A., Zigmond M.J. Low concentrations of methamphetamine can protect dopaminergic cells against a larger oxidative stress injury: mechanistic study. PLoS ONE 2011, 6:e24722.
91. Faherty C.J., Raviie Shepherd K., Herasimtschuk A., Smeyne R.J. Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism. Brain Res. Mol. Brain Res. 2005, 134:170-179.
92. Fan G.H., Qi C., Chen S.D. Heat shock proteins reduce toxicity of 1-methyl-4-phenylpyridinium ion in SK-N-SH cells. J. Neurosci. Res. 2005, 82:551-562.
93. Fan G.H., Zhou H.Y., Yang H., Chen S.D. Heat shock proteins reduce alpha-synuclein aggregation induced by MPP+ in SK-N-SH cells. FEBS Lett. 2006, 580:3091-3098.
94. Fan Y.Y., Hu W.W., Dai H.B., Zhang J.X., Zhang L.Y., He P., Shen Y., Ohtsu H., Wei E.Q., Chen Z. Activation of the central histaminergic system is involved in hypoxia-induced stroke tolerance in adult mice. J. Cereb. Blood Flow Metab. 2011, 31:305-314.
95. Freiberger J.J., Suliman H.B., Sheng H., McAdoo J., Piantadosi C.A., Warner D.S. A comparison of hyperbaric oxygen versus hypoxic cerebral preconditioning in neonatal rats. Brain Res. 2006, 1075:213-222.
96. Furuya K., Zhu L., Kawahara N., Abe O., Kirino T. Differences in infarct evolution between lipopolysaccharide-induced tolerant and nontolerant conditions to focal cerebral ischemia. J. Neurosurg. 2005, 103:715-723.
97. Gage A.T., Stanton P.K. Hypoxia triggers neuroprotective alterations in hippocampal gene expression via a heme-containing sensor. Brain Res. 1996, 719:172-178.
98. Gao C.J., Niu L., Ren P.C., Wang W., Zhu C., Li Y.Q., Chai W., Sun X.D. Hypoxic preconditioning attenuates global cerebral ischemic injury following asphyxial cardiac arrest through regulation of delta opioid receptor system. Neuroscience 2012, 202:352-362.
99. Gao X., Ren C., Zhao H. Protective effects of ischemic postconditioning compared with gradual reperfusion or preconditioning. J. Neurosci. Res. 2008, 86:2505-2511.
100. Geng X., Ren C., Wang T., Fu P., Luo Y., Liu X., Yan F., Ling F., Jia J., Du H., Ji X., Ding Y. Effect of remote ischemic postconditioning on an intracerebral hemorrhage stroke model in rats. Neurol. Res. 2012, 34:143-148.
101. Gerecke K.M., Jiao Y., Pani A., Pagala V., Smeyne R.J. Exercise protects against MPTP-induced neurotoxicity in mice. Brain Res. 2010, 1341:72-83.
102. Gidday J.M., Fitzgibbons J.C., Shah A.R., Park T.S. Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat. Neurosci. Lett. 1994, 168:221-224.
103. Gill M.B., Perez-Polo J.R. Hypoxia ischemia-mediated cell death in neonatal rat brain. Neurochem. Res. 2008, 33:2379-2389.
104. Giorguieff-Chesselet M.F., Kemel M.L., Wandscheer D., Glowinski J. Regulation of dopamine release by presynaptic nicotinic receptors in rat striatal slices: effect of nicotine in a low concentration. Life Sci. 1979, 25:1257-1262.
105. Gniel H.M., Martin R.L. Cortical spreading depression-induced preconditioning in mouse neocortex is lamina specific. J. Neurophysiol. 2013, 109:2923-2936.
106. Gobbi L.T., Oliveira-Ferreira M.D., Caetano M.J., Lirani-Silva E., Barbieri F.A., Stella F., Gobbi S. Exercise programs improve mobility and balance in people with Parkinson's disease. Parkinsonism Relat. Disord. 2009, 15(Suppl. 3):S49-S52.
107. Gorman A.M., Szegezdi E., Quigney D.J., Samali A. Hsp27 inhibits 6-hydroxydopamine-induced cytochrome c release and apoptosis in PC12 cells. Biochem. Biophys. Res. Commun. 2005, 327:801-810.
108. Grabb M.C., Choi D.W. Ischemic tolerance in murine cortical cell culture: critical role for NMDA receptors. J. Neurosci. 1999, 19:1657-1662.
109. Graham D.I., Adams J.H., Murray L.S., Jennett B. Neuropathology of the vegetative state after head injury. Neuropsychol. Rehabil. 2005, 15:198-213.
110. Graham D.L., Noailles P.A., Cadet J.L. Differential neurochemical consequences of an escalating dose-binge regimen followed by single-day multiple-dose methamphetamine challenges. J. Neurochem. 2008, 105:1873-1885.
111. Granziera C., Thevenet J., Price M., Wiegler K., Magistretti P.J., Badaut J., Hirt L. Thrombin-induced ischemic tolerance is prevented by inhibiting c-jun N-terminal kinase. Brain Res. 2007, 1148:217-225.
112. Grenhoff J., Svensson T.H. Pharmacology of nicotine. Br. J. Addict. 1989, 84:477-492.
113. Gustavsson M., Anderson M.F., Mallard C., Hagberg H. Hypoxic preconditioning confers long-term reduction of brain injury and improvement of neurological ability in immature rats. Pediatr. Res. 2005, 57:305-309.
114. Halagappa V.K., Guo Z., Pearson M., Matsuoka Y., Cutler R.G., Laferla F.M., Mattson M.P. Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease. Neurobiol. Dis. 2007, 26:212-220.
115. Hands S.L., Proud C.G., Wyttenbach A. mTOR's role in ageing: protein synthesis or autophagy?. Aging (Albany NY) 2009, 1:586-597.
116. Hara H., Kamiya T., Adachi T. Endoplasmic reticulum stress inducers provide protection against 6-hydroxydopamine-induced cytotoxicity. Neurochem. Int. 2011, 58:35-43.
117. Hausenloy D.J., Yellon D.M. Preconditioning and postconditioning: underlying mechanisms and clinical application. Atherosclerosis 2009, 204:334-341.
118. Hausenloy D.J., Yellon D.M. The therapeutic potential of ischemic conditioning: an update. Nat. Rev. Cardiol. 2011, 8:619-629.
119. He Z., Crook J.E., Meschia J.F., Brott T.G., Dickson D.W., McKinney M. Aging blunts ischemic-preconditioning-induced neuroprotection following transient global ischemia in rats. Curr. Neurovasc. Res. 2005, 2:365-374.
120. Head B.P., Patel H.H., Tsutsumi Y.M., Hu Y., Mejia T., Mora R.C., Insel P.A., Roth D.M., Drummond J.C., Patel P.M. Caveolin-1 expression is essential for N-methyl-d-aspartate receptor-mediated Src and extracellular signal-regulated kinase 1/2 activation and protection of primary neurons from ischemic cell death. FASEB J. 2008, 22:828-840.
121. Heyer E.J., Sharma R., Rampersad A., Winfree C.J., Mack W.J., Solomon R.A., Todd G.J., McCormick P.C., McMurtry J.G., Quest D.O., Stern Y., Lazar R.M., Connolly E.S. A controlled prospective study of neuropsychological dysfunction following carotid endarterectomy. Arch. Neurol. 2002, 59:217-222.
122. Hickey E.J., You X., Kaimaktchiev V., Stenzel-Poore M., Ungerleider R.M. Lipopolysaccharide preconditioning induces robust protection against brain injury resulting from deep hypothermic circulatory arrest. J. Thorac. Cardiovasc. Surg. 2007, 133:1588-1596.
123. Holmer H.K., Keyghobadi M., Moore C., Menashe R.A., Meshul C.K. Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration. Synapse 2005, 57:100-112.
124. Honjoh S., Nishida E. Two sides of lifespan regulating genes: pro-longevity or anti-longevity?. J. Biochem. 2011, 149:381-388.
125. Horiguchi T., Kis B., Rajapakse N., Shimizu K., Busija D.W. Opening of mitochondrial ATP-sensitive potassium channels is a trigger of 3-nitropropionic acid-induced tolerance to transient focal cerebral ischemia in rats. Stroke 2003, 34:1015-1020.
126. Hoshi A., Nakahara T., Kayama H., Yamamoto T. Ischemic tolerance in chemical preconditioning: possible role of astrocytic glutamine synthetase buffering glutamate-mediated neurotoxicity. J. Neurosci. Res. 2006, 84:130-141.
127. Hoshi A., Nakahara T., Ogata M., Yamamoto T. The critical threshold of 3-nitropropionic acid-induced ischemic tolerance in the rat. Brain Res. 2005, 1050:33-39.
128. Hu S., Dong H., Zhang H., Wang S., Hou L., Chen S., Zhang J., Xiong L. Noninvasive limb remote ischemic preconditioning contributes neuroprotective effects via activation of adenosine A1 receptor and redox status after transient focal cerebral ischemia in rats. Brain Res. 2012, 1459:81-90.
129. Hu S., Dong H.L., Li Y.Z., Luo Z.J., Sun L., Yang Q.Z., Yang L.F., Xiong L. Effects of remote ischemic preconditioning on biochemical markers and neurologic outcomes in patients undergoing elective cervical decompression surgery: a prospective randomized controlled trial. J. Neurosurg. Anesthesiol. 2010, 22:46-52.
130. Hu S., Li F., Luo H., Xia Y., Zhang J., Hu R., Cui G., Meng H., Feng H. Amelioration of rCBF and PbtO2 following TBI at high altitude by hyperbaric oxygen pre-conditioning. Neurol. Res. 2010, 32:173-178.
131. Hu S.L., Hu R., Li F., Liu Z., Xia Y.Z., Cui G.Y., Feng H. Hyperbaric oxygen preconditioning protects against traumatic brain injury at high altitude. Acta Neurochir. Suppl. 2008, 105:191-196.
132. Hu X., Zheng H., Yan T., Pan S., Fang J., Jiang R., Ma S. Physical exercise induces expression of CD31 and facilitates neural function recovery in rats with focal cerebral infarction. Neurol. Res. 2010, 32:397-402.
133. Hua F., Ma J., Ha T., Kelley J., Williams D.L., Kao R.L., Kalbfleisch J.H., Browder I.W., Li C. Preconditioning with a TLR2 specific ligand increases resistance to cerebral ischemia/reperfusion injury. J. Neuroimmunol. 2008, 199:75-82.
134. Hua Y., Wu J., Pecina S., Yang S., Schallert T., Keep R.F., Xi G. Ischemic preconditioning procedure induces behavioral deficits in the absence of brain injury?. Neurol. Res. 2005, 27:261-267.
135. Hunter R.L., Cheng B., Choi D.Y., Liu M., Liu S., Cass W.A., Bing G. Intrastriatal lipopolysaccharide injection induces parkinsonism in C57/B6 mice. J. Neurosci. Res. 2009, 87:1913-1921.
136. Hunter R.L., Dragicevic N., Seifert K., Choi D.Y., Liu M., Kim H.C., Cass W.A., Sullivan P.G., Bing G. Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system. J. Neurochem. 2007, 100:1375-1386.
137. Ingram D.K., Weindruch R., Spangler E.L., Freeman J.R., Walford R.L. Dietary restriction benefits learning and motor performance of aged mice. J. Gerontol. 1987, 42:78-81.
138. Ingram D.K., Young J., Mattison J.A. Calorie restriction in nonhuman primates: assessing effects on brain and behavioral aging. Neuroscience 2007, 145:1359-1364.
139. Jackson-Lewis V., Blesa J., Przedborski S. Animal models of Parkinson's disease. Parkinsonism Relat. Disord. 2012, 18(Suppl. 1):S183-S185.
140. Jadhav V., Ostrowski R.P., Tong W., Matus B., Chang C., Zhang J.H. Hyperbaric oxygen preconditioning reduces postoperative brain edema and improves neurological outcomes after surgical brain injury. Acta Neurochir. Suppl. 2010, 106:217-220.
141. Jadhav V., Ostrowski R.P., Tong W., Matus B., Jesunathadas R., Zhang J.H. Cyclo-oxygenase-2 mediates hyperbaric oxygen preconditioning-induced neuroprotection in the mouse model of surgical brain injury. Stroke 2009, 40:3139-3142.
142. Jadhav, V., Solaroglu, I., Obenaus, A., Zhang, J.H., 2007. Neuroprotection against surgically induced brain injury. Surg. Neurol. 67, 15-20 (discussion 20).
143. Jadhav V., Zhang J.H. Surgical brain injury: prevention is better than cure. Front. Biosci. 2008, 13:3793-3797.
144. Jadiya P., Chatterjee M., Sammi S.R., Kaur S., Palit G., Nazir A. Sir-2.1 modulates 'calorie-restriction-mediated' prevention of neurodegeneration in Caenorhabditis elegans: implications for Parkinson's disease. Biochem. Biophys. Res. Commun. 2011, 413:306-310.
145. Jensen H.A., Loukogeorgakis S., Yannopoulos F., Rimpilainen E., Petzold A., Tuominen H., Lepola P., Macallister R.J., Deanfield J.E., Makela T., Alestalo K., Kiviluoma K., Anttila V., Tsang V., Juvonen T. Remote ischemic preconditioning protects the brain against injury after hypothermic circulatory arrest. Circulation 2011, 123:714-721.
146. Jeon Y.T., Hwang J.W., Lim Y.J., Kim A.N., Park H.P. A combination of sevoflurane postconditioning and albumin increases Bcl-2 expression after transient global cerebral ischemia compared with either sevoflurane postconditioning or albumin alone. J. Neurosurg. Anesthesiol. 2013, 25:43-50.
147. Jia J., Hu Y.S., Wu Y., Liu G., Yu H.X., Zheng Q.P., Zhu D.N., Xia C.M., Cao Z.J. Pre-ischemic treadmill training affects glutamate and gamma aminobutyric acid levels in the striatal dialysate of a rat model of cerebral ischemia. Life Sci. 2009, 84:505-511.
148. Jia K., Chen D., Riddle D.L. The TOR pathway interacts with the insulin signaling pathway to regulate C. elegans larval development, metabolism and life span. Development 2004, 131:3897-3906.
149. Jiang X., Tian F., Mearow K., Okagaki P., Lipsky R.H., Marini A.M. The excitoprotective effect of N-methyl-d-aspartate receptors is mediated by a brain-derived neurotrophic factor autocrine loop in cultured hippocampal neurons. J. Neurochem. 2005, 94:713-722.
150. Johnson-Davis K.L., Fleckenstein A.E., Wilkins D.G. The role of hyperthermia and metabolism as mechanisms of tolerance to methamphetamine neurotoxicity. Eur. J. Pharmacol. 2003, 482:151-154.
151. Johnson-Davis K.L., Truong J.G., Fleckenstein A.E., Wilkins D.G. Alterations in vesicular dopamine uptake contribute to tolerance to the neurotoxic effects of methamphetamine. J. Pharmacol. Exp. Ther. 2004, 309:578-586.
152. Johnston S.C. Ischemic preconditioning from transient ischemic attacks? Data from the Northern California TIA Study. Stroke 2004, 35:2680-2682.
153. Jung C.H., Ro S.H., Cao J., Otto N.M., Kim D.H. mTOR regulation of autophagy. FEBS Lett. 2010, 584:1287-1295.
154. Kalmijn S., Launer L.J., Ott A., Witteman J.C., Hofman A., Breteler M.M. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann. Neurol. 1997, 42:776-782.
155. Kawahara N., Ruetzler C.A., Klatzo I. Protective effect of spreading depression against neuronal damage following cardiac arrest cerebral ischaemia. Neurol. Res. 1995, 17:9-16.
156. Keep R.F., Wang M.M., Xiang J., Hua Y., Xi G. Is there a place for cerebral preconditioning in the clinic?. Transl. Stroke Res. 2010, 1:4-18.
157. Kenyon C. The first long-lived mutants: discovery of the insulin/IGF-1 pathway for ageing. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2011, 366:9-16.
158. Kersten J.R., Schmeling T.J., Pagel P.S., Gross G.J., Warltier D.C. Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels: reduction of myocardial infarct size with an acute memory phase. Anesthesiology 1997, 87:361-370.
159. Kim H.J., Lee J.H., Kim S.H. Therapeutic effects of human mesenchymal stem cells on traumatic brain injury in rats: secretion of neurotrophic factors and inhibition of apoptosis. J. Neurotrauma 2010, 27:131-138.
160. Kim H.W., Haider H.K., Jiang S., Ashraf M. Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. J. Biol. Chem. 2009, 284:33161-33168.
161. Kim S.C., Stice J.P., Chen L., Jung J.S., Gupta S., Wang Y., Baumgarten G., Trial J., Knowlton A.A. Extracellular heat shock protein 60, cardiac myocytes, and apoptosis. Circ. Res. 2009, 105:1186-1195.
162. Kim S.H., Kim E.H., Lee B.I., Heo J.H. Chronic cerebral hypoperfusion protects against acute focal ischemia, improves motor function, and results in vascular remodeling. Curr. Neurovasc. Res. 2008, 5:28-36.
163. Kim, Y.W., Ogilvy, C.S., Pricola, K., Reavey-Cantwell, J.F., Kelman, C.R., Zipfel, G.J., Washington, C., Albuquerque, F., Kalani, M.Y.S., Hoh, B.L., 2012. Evidence for an ischemic preconditioning effect on cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. In: Congress of Neurological Surgeons, Chicago, IL, p. E553.
164. Kirino T., Tsujita Y., Tamura A. Induced tolerance to ischemia in gerbil hippocampal neurons. J. Cereb. Blood Flow Metab. 1991, 11:299-307.
165. Kis B., Nagy K., Snipes J.A., Rajapakse N.C., Horiguchi T., Grover G.J., Busija D.W. The mitochondrial K(ATP) channel opener BMS-191095 induces neuronal preconditioning. Neuroreport 2004, 15:345-349.
166. Kis B., Rajapakse N.C., Snipes J.A., Nagy K., Horiguchi T., Busija D.W. Diazoxide induces delayed pre-conditioning in cultured rat cortical neurons. J. Neurochem. 2003, 87:969-980.
167. Kita T., Wagner G.C., Nakashima T. Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption. J. Pharmacol. Sci. 2003, 92:178-195.
168. Kitagawa K., Matsumoto M., Kuwabara K., Tagaya M., Ohtsuki T., Hata R., Ueda H., Handa N., Kimura K., Kamada T. 'Ischemic tolerance' phenomenon detected in various brain regions. Brain Res. 1991, 561:203-211.
169. Kitagawa K., Matsumoto M., Tagaya M., Hata R., Ueda H., Niinobe M., Handa N., Fukunaga R., Kimura K., Mikoshiba K. 'Ischemic tolerance' phenomenon found in the brain. Brain Res. 1990, 528:21-24.
170. Kitano H., Young J.M., Cheng J., Wang L., Hurn P.D., Murphy S.J. Gender-specific response to isoflurane preconditioning in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 2007, 27:1377-1386.
171. Kloner R.A., Shook T., Przyklenk K., Davis V.G., Junio L., Matthews R.V., Burstein S., Gibson M., Poole W.K., Cannon C.P. Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning?. Circulation 1995, 91:37-45.
172. Koch S., Katsnelson M., Dong C., Perez-Pinzon M. Remote ischemic limb preconditioning after subarachnoid hemorrhage: a phase Ib study of safety and feasibility. Stroke 2011, 42:1387-1391.
173. Kouda K., Iki M. Beneficial effects of mild stress (hormetic effects): dietary restriction and health. J. Physiol. Anthropol. 2010, 29:127-132.
174. Krenz M., Korthuis R.J. Moderate ethanol ingestion and cardiovascular protection: from epidemiologic associations to cellular mechanisms. J. Mol. Cell Cardiol. 2012, 52:93-104.
175. Kunz A., Park L., Abe T., Gallo E.F., Anrather J., Zhou P., Iadecola C. Neurovascular protection by ischemic tolerance: role of nitric oxide and reactive oxygen species. J. Neurosci. 2007, 27:7083-7093.
176. Kuroiwa T., Yamada I., Endo S., Hakamata Y., Ito U. 3-Nitropropionic acid preconditioning ameliorates delayed neurological deterioration and infarction after transient focal cerebral ischemia in gerbils. Neurosci. Lett. 2000, 283:145-148.
177. Langdon K.D., Maclellan C.L., Corbett D. Prolonged, 24-h delayed peripheral inflammation increases short- and long-term functional impairment and histopathological damage after focal ischemia in the rat. J. Cereb. Blood Flow Metab. 2010, 30:1450-1459.
178. Lastres-Becker I., Cartmell T., Molina-Holgado F. Endotoxin preconditioning protects neurones from in vitro ischemia: role of endogenous IL-1beta and TNF-alpha. J. Neuroimmunol. 2006, 173:108-116.
179. Lau Y.S., Patki G., Das-Panja K., Le W.D., Ahmad S.O. Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson's disease with moderate neurodegeneration. Eur. J. Neurosci. 2011, 33:1264-1274.
180. Leak R.K., Liou A.K., Zigmond M.J. Effect of sublethal 6-hydroxydopamine on the response to subsequent oxidative stress in dopaminergic cells: evidence for preconditioning. J. Neurochem. 2006, 99:1151-1163.
181. Leak R.K., Zigmond M.J., Liou A.K. Adaptation to chronic MG132 reduces oxidative toxicity by a CuZnSOD-dependent mechanism. J. Neurochem. 2008, 106:860-874.
182. Lee H.M., Lee D.H., Choi J.H., Lee S.R., Kim Y.W., Jee D.L., Do H.S., Park S.J. Sevoflurane-induced post-conditioning has no beneficial effects on neuroprotection after incomplete cerebral ischemia in rats. Acta Anaesthesiol. Scand. 2010, 54:328-336.
183. Lee J.J., Li L., Jung H.H., Zuo Z. Postconditioning with isoflurane reduced ischemia-induced brain injury in rats. Anesthesiology 2008, 108:1055-1062.
184. Lee K.R., Betz A.L., Keep R.F., Chenevert T.L., Kim S., Hoff J.T. Intracerebral infusion of thrombin as a cause of brain edema. J. Neurosurg. 1995, 83:1045-1050.
185. Lee, K.R., Betz, A.L., Kim, S., Keep, R.F., Hoff, J.T., 1996a. The role of the coagulation cascade in brain edema formation after intracerebral hemorrhage. Acta Neurochir. (Wien) 138, 396-400 (discussion 400-391).
186. Lee K.R., Colon G.P., Betz A.L., Keep R.F., Kim S., Hoff J.T. Edema from intracerebral hemorrhage: the role of thrombin. J. Neurosurg. 1996, 84:91-96.
187. Lee K.R., Drury I., Vitarbo E., Hoff J.T. Seizures induced by intracerebral injection of thrombin: a model of intracerebral hemorrhage. J. Neurosurg. 1997, 87:73-78.
188. Leger P.L., Bonnin P., Nguyen T., Renolleau S., Baud O., Charriaut-Marlangue C. Ischemic postconditioning fails to protect against neonatal cerebral stroke. PLoS ONE 2012, 7:e49695.
189. Leibson C.L., Rocca W.A., Hanson V.A., Cha R., Kokmen E., O'Brien P.C., Palumbo P.J. The risk of dementia among persons with diabetes mellitus: a population-based cohort study. Ann. N. Y. Acad. Sci. 1997, 826:422-427.
190. Lenzser G., Kis B., Bari F., Busija D.W. Diazoxide preconditioning attenuates global cerebral ischemia-induced blood-brain barrier permeability. Brain Res. 2005, 1051:72-80.
191. Leung P.Y., Stevens S.L., Packard A.E., Lessov N.S., Yang T., Conrad V.K., van den Dungen N.N., Simon R.P., Stenzel-Poore M.P. Toll-like receptor 7 preconditioning induces robust neuroprotection against stroke by a novel type I interferon-mediated mechanism. Stroke 2012, 43:1383-1389.
192. Li J., Luan X., Clark J.C., Rafols J.A., Ding Y. Neuroprotection against transient cerebral ischemia by exercise pre-conditioning in rats. Neurol. Res. 2004, 26:404-408.
193. Li J.S., Zhang W., Kang Z.M., Ding S.J., Liu W.W., Zhang J.H., Guan Y.T., Sun X.J. Hyperbaric oxygen preconditioning reduces ischemia-reperfusion injury by inhibition of apoptosis via mitochondrial pathway in rat brain. Neuroscience 2009, 159:1309-1315.
194. Li L., Zuo Z. Isoflurane preconditioning improves short-term and long-term neurological outcome after focal brain ischemia in adult rats. Neuroscience 2009, 164:497-506.
195. Li Q.F., Zhu Y.S., Jiang H. Isoflurane preconditioning activates HIF-1alpha, iNOS and Erk1/2 and protects against oxygen-glucose deprivation neuronal injury. Brain Res. 2008, 1245:26-35.
196. Li Y., Dong H., Chen M., Liu J., Yang L., Chen S., Xiong L. Preconditioning with repeated hyperbaric oxygen induces myocardial and cerebral protection in patients undergoing coronary artery bypass graft surgery: a prospective, randomized, controlled clinical trial. J. Cardiothorac. Vasc. Anesth. 2011, 25:908-916.
197. Li Y., Xiao D., Dasgupta C., Xiong F., Tong W., Yang S., Zhang L. Perinatal nicotine exposure increases vulnerability of hypoxic-ischemic brain injury in neonatal rats: role of angiotensin II receptors. Stroke 2012, 43:2483-2490.
198. Li Z., Liu W., Kang Z., Lv S., Han C., Yun L., Sun X., Zhang J.H. Mechanism of hyperbaric oxygen preconditioning in neonatal hypoxia-ischemia rat model. Brain Res. 2008, 1196:151-156.
199. Liang B.T., Gross G.J. Direct preconditioning of cardiac myocytes via opioid receptors and KATP channels. Circ. Res. 1999, 84:1396-1400.
200. Liao S.L., Chen W.Y., Raung S.L., Chen C.J. Ethanol attenuates ischemic and hypoxic injury in rat brain and cultured neurons. Neuroreport 2003, 14:2089-2094.
201. Liebelt B., Papapetrou P., Ali A., Guo M., Ji X., Peng C., Rogers R., Curry A., Jimenez D., Ding Y. Exercise preconditioning reduces neuronal apoptosis in stroke by up-regulating heat shock protein-70 (heat shock protein-72) and extracellular-signal-regulated-kinase 1/2. Neuroscience 2010, 166:1091-1100.
202. Lim C.L., Byrne C., Lee J.K. Human thermoregulation and measurement of body temperature in exercise and clinical settings. Ann. Acad. Med. Singapore 2008, 37:347-353.
203. Lim S.Y., Yellon D.M., Hausenloy D.J. The neural and humoral pathways in remote limb ischemic preconditioning. Basic Res. Cardiol. 2010, 105:651-655.
204. Lin, A.M., Dung, S.W., Chen, C.F., Chen, W.H., Ho, L.T., 2003. Hypoxic preconditioning prevents cortical infarction by transient focal ischemia-reperfusion. Ann. N. Y. Acad. Sci. 993, 168-178 (discussion 195-166).
205. Lin H.Y., Huang C.C., Chang K.F. Lipopolysaccharide preconditioning reduces neuroinflammation against hypoxic ischemia and provides long-term outcome of neuroprotection in neonatal rat. Pediatr. Res. 2009, 66:254-259.
206. Lin S.J., Kaeberlein M., Andalis A.A., Sturtz L.A., Defossez P.A., Culotta V.C., Fink G.R., Guarente L. Calorie restriction extends Saccharomyces cerevisiae lifespan by increasing respiration. Nature 2002, 418:344-348.
207. Lin W.Y., Chang Y.C., Lee H.T., Huang C.C. CREB activation in the rapid, intermediate, and delayed ischemic preconditioning against hypoxic-ischemia in neonatal rat. J. Neurochem. 2009, 108:847-859.
208. Ling Z., Chang Q.A., Tong C.W., Leurgans S.E., Lipton J.W., Carvey P.M. Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally. Exp. Neurol. 2004, 190:373-383.
209. Ling Z., Gayle D.A., Ma S.Y., Lipton J.W., Tong C.W., Hong J.S., Carvey P.M. In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain. Mov. Disord. 2002, 17:116-124.
210. Lipsky R.H., Xu K., Zhu D., Kelly C., Terhakopian A., Novelli A., Marini A.M. Nuclear factor kappaB is a critical determinant in N-methyl-d-aspartate receptor-mediated neuroprotection. J. Neurochem. 2001, 78:254-264.
211. Liu C., Weaver J., Liu K.J. Rapid conditioning with oxygen oscillation: neuroprotection by intermittent normobaric hyperoxia after transient focal cerebral ischemia in rats. Stroke 2012, 43:220-226.
212. Liu M., Alkayed N.J. Hypoxic preconditioning and tolerance via hypoxia inducible factor (HIF) 1alpha-linked induction of P450 2C11 epoxygenase in astrocytes. J. Cereb. Blood Flow Metab. 2005, 25:939-948.
213. Liu Y., Kato H., Nakata N., Kogure K. Protection of rat hippocampus against ischemic neuronal damage by pretreatment with sublethal ischemia. Brain Res. 1992, 586:121-124.
214. Liu Y., Li J., Yang J., Ji F., Bu X., Zhang N., Zhang B. Inhibition of PKCgamma membrane translocation mediated morphine preconditioning-induced neuroprotection against oxygen-glucose deprivation in the hippocampus slices of mice. Neurosci. Lett. 2008, 444:87-91.
215. Liu Y., Qin L., Wilson B., Wu X., Qian L., Granholm A.C., Crews F.T., Hong J.S. Endotoxin induces a delayed loss of TH-IR neurons in substantia nigra and motor behavioral deficits. Neurotoxicology 2008, 29:864-870.
216. Lo E.H. A new penumbra: transitioning from injury into repair after stroke. Nat. Med. 2008, 14:497-500.
217. Logroscino G., Marder K., Cote L., Tang M.X., Shea S., Mayeux R. Dietary lipids and antioxidants in Parkinson's disease: a population-based, case-control study. Ann. Neurol. 1996, 39:89-94.
218. Love R. Calorie restriction may be neuroprotective in AD and PD. Lancet Neurol. 2005, 4:84.
219. Luo Y., Ma D., Ieong E., Sanders R.D., Yu B., Hossain M., Maze M. Xenon and sevoflurane protect against brain injury in a neonatal asphyxia model. Anesthesiology 2008, 109:782-789.
220. Malhotra S., Naggar I., Stewart M., Rosenbaum D.M. Neurogenic pathway mediated remote preconditioning protects the brain from transient focal ischemic injury. Brain Res. 2011, 1386:184-190.
221. Mandavilli B.S., Boldogh I., Van Houten B. 3-nitropropionic acid-induced hydrogen peroxide, mitochondrial DNA damage, and cell death are attenuated by Bcl-2 overexpression in PC12 cells. Brain Res. Mol. Brain Res. 2005, 133:215-223.
222. Mandir A.S., Poitras M.F., Berliner A.R., Herring W.J., Guastella D.B., Feldman A., Poirier G.G., Wang Z.Q., Dawson T.M., Dawson V.L. NMDA but not non-NMDA excitotoxicity is mediated by poly(ADP-ribose) polymerase. J. Neurosci. 2000, 20:8005-8011.
223. Marini A., Novelli A. DL-threo-3-hydroxyaspartate reduces NMDA receptor activation by glutamate in cultured neurons. Eur. J. Pharmacol. 1991, 194:131-132.
224. Marini A.M., Paul S.M. N-methyl-D-aspartate receptor-mediated neuroprotection in cerebellar granule cells requires new RNA and protein synthesis. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:6555-6559.
225. Marini A.M., Popolo M., Pan H., Blondeau N., Lipsky R.H. Brain adaptation to stressful stimuli: a new perspective on potential therapeutic approaches based on BDNF and NMDA receptors. CNS Neurol. Disord. Drug Targets 2008, 7:382-390.
226. Marini A.M., Rabin S.J., Lipsky R.H., Mocchetti I. Activity-dependent release of brain-derived neurotrophic factor underlies the neuroprotective effect of N-methyl-d-aspartate. J. Biol. Chem. 1998, 273:29394-29399.
227. Marsh B., Stevens S.L., Packard A.E., Gopalan B., Hunter B., Leung P.Y., Harrington C.A., Stenzel-Poore M.P. Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: a critical role for IRF3. J. Neurosci. 2009, 29:9839-9849.
228. Maswood N., Young J., Tilmont E., Zhang Z., Gash D.M., Gerhardt G.A., Grondin R., Roth G.S., Mattison J., Lane M.A., Carson R.E., Cohen R.M., Mouton P.R., Quigley C., Mattson M.P., Ingram D.K. Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:18171-18176.
229. Matsushima K., Hakim A.M. Transient forebrain ischemia protects against subsequent focal cerebral ischemia without changing cerebral perfusion. Stroke 1995, 26:1047-1052.
230. Matsushima K., Hogan M.J., Hakim A.M. Cortical spreading depression protects against subsequent focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 1996, 16:221-226.
231. Mattson M.P., Chan S.L., Duan W. Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior. Physiol. Rev. 2002, 82:637-672.
232. Mattson M.P., Duan W., Wan R., Guo Z. Prophylactic activation of neuroprotective stress response pathways by dietary and behavioral manipulations. NeuroRx 2004, 1:111-116.
233. Mayanagi K., Gaspar T., Katakam P.V., Kis B., Busija D.W. The mitochondrial K(ATP) channel opener BMS-191095 reduces neuronal damage after transient focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 2007, 27:348-355.
234. McAuliffe J.J., Joseph B., Vorhees C.V. Isoflurane-delayed preconditioning reduces immediate mortality and improves striatal function in adult mice after neonatal hypoxia-ischemia. Anesth. Analg. 2007, 104:1066-1077.
235. McAuliffe J.J., Loepke A.W., Miles L., Joseph B., Hughes E., Vorhees C.V. Desflurane, isoflurane, and sevoflurane provide limited neuroprotection against neonatal hypoxia-ischemia in a delayed preconditioning paradigm. Anesthesiology 2009, 111:533-546.
236. McCullough, J.N., Zhang, N., Reich, D.L., Juvonen, T.S., Klein, J.J., Spielvogel, D., Ergin, M.A., Griepp, R.B., 1999. Cerebral metabolic suppression during hypothermic circulatory arrest in humans. Ann. Thorac. Surg. 67, 1895-1899 (discussion 1919-1821).
237. McKee A.C., Stein T.D., Nowinski C.J., Stern R.A., Daneshvar D.H., Alvarez V.E., Lee H.S., Hall G., Wojtowicz S.M., Baugh C.M., Riley D.O., Kubilus C.A., Cormier K.A., Jacobs M.A., Martin B.R., Abraham C.R., Ikezu T., Reichard R.R., Wolozin B.L., Budson A.E., Goldstein L.E., Kowall N.W., Cantu R.C. The spectrum of disease in chronic traumatic encephalopathy. Brain 2013, 136:43-64.
238. McNaught K.S., Belizaire R., Isacson O., Jenner P., Olanow C.W. Altered proteasomal function in sporadic Parkinson's disease. Exp. Neurol. 2003, 179:38-46.
239. Mehlig K., Skoog I., Guo X., Schutze M., Gustafson D., Waern M., Ostling S., Bjorkelund C., Lissner L. Alcoholic beverages and incidence of dementia: 34-year follow-up of the prospective population study of women in Goteborg. Am. J. Epidemiol. 2008, 167:684-691.
240. Meng R., Asmaro K., Meng L., Liu Y., Ma C., Xi C., Li G., Ren C., Luo Y., Ling F., Jia J., Hua Y., Wang X., Ding Y., Lo E.H., Ji X. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology 2012, 79:1853-1861.
241. Mercken E.M., Carboneau B.A., Krzysik-Walker S.M., de Cabo R. Of mice and men: the benefits of caloric restriction, exercise, and mimetics. Ageing Res. Rev. 2012, 11:390-398.
242. Meybohm P., Gruenewald M., Zacharowski K.D., Albrecht M., Lucius R., Fosel N., Hensler J., Zitta K., Bein B. Mild hypothermia alone or in combination with anesthetic post-conditioning reduces expression of inflammatory cytokines in the cerebral cortex of pigs after cardiopulmonary resuscitation. Crit. Care 2010, 14:R21.
243. Meybohm P., Renner J., Broch O., Caliebe D., Albrecht M., Cremer J., Haake N., Scholz J., Zacharowski K., Bein B. Postoperative neurocognitive dysfunction in patients undergoing cardiac surgery after remote ischemic preconditioning: a double-blind randomized controlled pilot study. PLoS ONE 2013, 8:e64743.
244. Miller B.A., Perez R.S., Shah A.R., Gonzales E.R., Park T.S., Gidday J.M. Cerebral protection by hypoxic preconditioning in a murine model of focal ischemia-reperfusion. Neuroreport 2001, 12:1663-1669.
245. Mitchell R.M., Neafsey E.J., Collins M.A. Essential involvement of the NMDA receptor in ethanol preconditioning-dependent neuroprotection from amyloid-betain vitro. J. Neurochem. 2009, 111:580-588.
246. Moncayo J., de Freitas G.R., Bogousslavsky J., Altieri M., van Melle G. Do transient ischemic attacks have a neuroprotective effect?. Neurology 2000, 54:2089-2094.
247. Moroz I.A., Pecina S., Schallert T., Stewart J. Sparing of behavior and basal extracellular dopamine after 6-hydroxydopamine lesions of the nigrostriatal pathway in rats exposed to a prelesion sensitizing regimen of amphetamine. Exp. Neurol. 2004, 189:78-93.
248. Morton J.P., Kayani A.C., McArdle A., Drust B. The exercise-induced stress response of skeletal muscle, with specific emphasis on humans. Sports Med. 2009, 39:643-662.
249. Mouton P.R., Chachich M.E., Quigley C., Spangler E., Ingram D.K. Caloric restriction attenuates amyloid deposition in middle-aged dtg APP/PS1 mice. Neurosci. Lett. 2009, 464:184-187.
250. Muir K.W. Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists. Curr. Opin. Pharmacol. 2006, 6:53-60.
251. Mukamal K.J., Kuller L.H., Fitzpatrick A.L., Longstreth W.T., Mittleman M.A., Siscovick D.S. Prospective study of alcohol consumption and risk of dementia in older adults. JAMA 2003, 289:1405-1413.
252. Muller D.W., Topol E.J., Califf R.M., Sigmon K.N., Gorman L., George B.S., Kereiakes D.J., Lee K.L., Ellis S.G. Relationship between antecedent angina pectoris and short-term prognosis after thrombolytic therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. Am. Heart J. 1990, 119:224-231.
253. Nagy K., Kis B., Rajapakse N.C., Bari F., Busija D.W. Diazoxide preconditioning protects against neuronal cell death by attenuation of oxidative stress upon glutamate stimulation. J. Neurosci. Res. 2004, 76:697-704.
254. Nakagawa, I., Alessandri, B., Heimann, A., Kempski, O., 2005. MitoKATP-channel opener protects against neuronal death in rat venous ischemia. Neurosurgery 57, 334-340 (discussion 334-340).
255. Nakagawa I., Wajima D., Tamura K., Nishimura F., Park Y.S., Nakase H. The neuroprotective effect of diazoxide is mediated by mitochondrial ATP-dependent potassium channels in a rat model of acute subdural hematoma. J. Clin. Neurosci. 2013, 20:144-147.
256. Nielsen S.S., Franklin G.M., Longstreth W.T., Swanson P.D., Checkoway H. Nicotine from edible Solanaceae and risk of Parkinson disease. Ann. Neurol. 2013, 74(3):472-477.
257. Nishino A., Suzuki M., Ohtani H., Motohashi O., Umezawa K., Nagura H., Yoshimoto T. Thrombin may contribute to the pathophysiology of central nervous system injury. J. Neurotrauma 1993, 10:167-179.
258. Nishio S., Chen Z.F., Yunoki M., Toyoda T., Anzivino M., Lee K.S. Hypothermia-induced ischemic tolerance. Ann. N. Y. Acad. Sci. 1999, 890:26-41.
259. Nishio S., Yunoki M., Chen Z.F., Anzivino M.J., Lee K.S. Ischemic tolerance in the rat neocortex following hypothermic preconditioning. J. Neurosurg. 2000, 93:845-851.
260. Nocera J., Horvat M., Ray C.T. Effects of home-based exercise on postural control and sensory organization in individuals with Parkinson disease. Parkinsonism Relat. Disord. 2009, 15:742-745.
261. Noiseux N., Borie M., Desnoyers A., Menaouar A., Stevens L.M., Mansour S., Danalache B.A., Roy D.C., Jankowski M., Gutkowska J. Preconditioning of stem cells by oxytocin to improve their therapeutic potential. Endocrinology 2012, 153:5361-5372.
262. Notkola I.L., Sulkava R., Pekkanen J., Erkinjuntti T., Ehnholm C., Kivinen P., Tuomilehto J., Nissinen A. Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology 1998, 17:14-20.
263. Ogita K., Okuda H., Yamamoto Y., Nishiyama N., Yoneda Y. In vivo neuroprotective role of NMDA receptors against kainate-induced excitotoxicity in murine hippocampal pyramidal neurons. J. Neurochem. 2003, 85:1336-1346.
264. Oldenburg O., Cohen M.V., Yellon D.M., Downey J.M. Mitochondrial K(ATP) channels: role in cardioprotection. Cardiovasc. Res. 2002, 55:429-437.
265. Olson J.K., Miller S.D. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 2004, 173:3916-3924.
266. Orgogozo J.M., Dartigues J.F., Lafont S., Letenneur L., Commenges D., Salamon R., Renaud S., Breteler M.B. Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev. Neurol. (Paris) 1997, 153:185-192.
267. Ostrowski R.P., Graupner G., Titova E., Zhang J., Chiu J., Dach N., Corleone D., Tang J., Zhang J.H. The hyperbaric oxygen preconditioning-induced brain protection is mediated by a reduction of early apoptosis after transient global cerebral ischemia. Neurobiol. Dis. 2008, 29:1-13.
268. Ota A., Ikeda T., Abe K., Sameshima H., Xia X.Y., Xia Y.X., Ikenoue T. Hypoxic-ischemic tolerance phenomenon observed in neonatal rat brain. Am. J. Obstet. Gynecol. 1998, 179:1075-1078.
269. Paradis S., Ruvkun G. Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes Dev. 1998, 12:2488-2498.
270. Park S.U., Ferrer J.V., Javitch J.A., Kuhn D.M. Peroxynitrite inactivates the human dopamine transporter by modification of cysteine 342: potential mechanism of neurotoxicity in dopamine neurons. J. Neurosci. 2002, 22:4399-4405.
271. Paulson J.R., Yang T., Selvaraj P.K., Mdzinarishvili A., Van der Schyf C.J., Klein J., Bickel U., Abbruscato T.J. Nicotine exacerbates brain edema during in vitro and in vivo focal ischemic conditions. J. Pharmacol. Exp. Ther. 2010, 332:371-379.
272. Payne R.S., Akca O., Roewer N., Schurr A., Kehl F. Sevoflurane-induced preconditioning protects against cerebral ischemic neuronal damage in rats. Brain Res. 2005, 1034:147-152.
273. Pepping J.K., Freeman L.R., Gupta S., Keller J.N., Bruce-Keller A.J. NOX2 deficiency attenuates markers of adiposopathy and brain injury induced by high-fat diet. Am. J. Physiol. Endocrinol. Metab. 2013, 304:E392-E404.
274. Pera J., Zawadzka M., Kaminska B., Szczudlik A. Influence of chemical and ischemic preconditioning on cytokine expression after focal brain ischemia. J. Neurosci. Res. 2004, 78:132-140.
275. Perez-Pinzon M.A., Xu G.P., Dietrich W.D., Rosenthal M., Sick T.J. Rapid preconditioning protects rats against ischemic neuronal damage after 3 but not 7 days of reperfusion following global cerebral ischemia. J. Cereb. Blood Flow Metab. 1997, 17:175-182.
276. Persky R.W., Turtzo L.C., McCullough L.D. Stroke in women: disparities and outcomes. Curr. Cardiol. Rep. 2010, 12:6-13.
277. Peters R., Peters J., Warner J., Beckett N., Bulpitt C. Alcohol, dementia and cognitive decline in the elderly: a systematic review. Age Ageing 2008, 37:505-512.
278. Petrovski G., Das D.K. Does autophagy take a front seat in lifespan extension?. J. Cell. Mol. Med. 2010, 14:2543-2551.
279. Petzinger G.M., Fisher B.E., Van Leeuwen J.E., Vukovic M., Akopian G., Meshul C.K., Holschneider D.P., Nacca A., Walsh J.P., Jakowec M.W. Enhancing neuroplasticity in the basal ganglia: the role of exercise in Parkinson's disease. Mov. Disord. 2010, 25(Suppl. 1):S141-S145.
280. Pinder R.M., Sandler M. Alcohol, wine and mental health: focus on dementia and stroke. J. Psychopharmacol. 2004, 18:449-456.
281. Poehlman E.T., Turturro A., Bodkin N., Cefalu W., Heymsfield S., Holloszy J., Kemnitz J. Caloric restriction mimetics: physical activity and body composition changes. J. Gerontol. A: Biol. Sci. Med. Sci. 2001, 56(Spec No 1):45-54.
282. Prass K., Scharff A., Ruscher K., Lowl D., Muselmann C., Victorov I., Kapinya K., Dirnagl U., Meisel A. Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin. Stroke 2003, 34:1981-1986.
283. Prins M.L., Giza C.C. Repeat traumatic brain injury in the developing brain. Int. J. Dev. Neurosci. 2011, 30:185-190.
284. Purcell J.E., Lenhard S.C., White R.F., Schaeffer T., Barone F.C., Chandra S. Strain-dependent response to cerebral ischemic preconditioning: differences between spontaneously hypertensive and stroke prone spontaneously hypertensive rats. Neurosci. Lett. 2003, 339:151-155.
285. Qian L., Flood P.M., Hong J.S. Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy. J. Neural. Transm. 2010, 117:971-979.
286. Qin W., Chachich M., Lane M., Roth G., Bryant M., de Cabo R., Ottinger M.A., Mattison J., Ingram D., Gandy S., Pasinetti G.M. Calorie restriction attenuates Alzheimer's disease type brain amyloidosis in Squirrel monkeys (Saimiri sciureus). J. Alzheimers Dis. 2006, 10:417-422.
287. Quigney D.J., Gorman A.M., Samali A. Heat shock protects PC12 cells against MPP+ toxicity. Brain Res. 2003, 993:133-139.
288. Quik M., Campos C., Grady S.R. Multiple CNS nicotinic receptors mediate l-dopa-induced dyskinesias; studies with parkinsonian nicotinic receptor knockout mice. Biochem. Pharmacol. 2013, 86:1153-1162.
289. Quik M., Huang L.Z., Parameswaran N., Bordia T., Campos C., Perez X.A. Multiple roles for nicotine in Parkinson's disease. Biochem. Pharmacol. 2009, 78:677-685.
290. Radak Z., Chung H.Y., Goto S. Systemic adaptation to oxidative challenge induced by regular exercise. Free Radic. Biol. Med. 2008, 44:153-159.
291. Radak Z., Taylor A.W., Ohno H., Goto S. Adaptation to exercise-induced oxidative stress: from muscle to brain. Exerc. Immunol. Rev. 2001, 7:90-107.
292. Rajapakse N., Kis B., Horiguchi T., Snipes J., Busija D. Diazoxide pretreatment induces delayed preconditioning in astrocytes against oxygen glucose deprivation and hydrogen peroxide-induced toxicity. J. Neurosci. Res. 2003, 73:206-214.
293. Rao V.L., Dogan A., Todd K.G., Bowen K.K., Dempsey R.J. Neuroprotection by memantine, a non-competitive NMDA receptor antagonist after traumatic brain injury in rats. Brain Res. 2001, 911:96-100.
294. Raval A.P., Dave K.R., Perez-Pinzon M.A. Resveratrol mimics ischemic preconditioning in the brain. J. Cereb. Blood Flow Metab. 2006, 26:1141-1147.
295. Raval A.P., Hirsch N., Dave K.R., Yavagal D.R., Bramlett H., Saul I. Nicotine and estrogen synergistically exacerbate cerebral ischemic injury. Neuroscience 2011, 181:216-225.
296. Rehni A.K., Singh T.G., Jaggi A.S., Singh N. Pharmacological preconditioning of the brain: a possible interplay between opioid and calcitonin gene related peptide transduction systems. Pharmacol. Rep. 2008, 60:904-913.
297. Ren C., Gao M., Dornbos III D., Ding Y., Zeng X., Luo Y., Ji X. Remote ischemic post-conditioning reduced brain damage in experimental ischemia/reperfusion injury. Neurol. Res. 2011, 33:514-519.
298. Ren C., Gao X., Steinberg G.K., Zhao H. Limb remote-preconditioning protects against focal ischemia in rats and contradicts the dogma of therapeutic time windows for preconditioning. Neuroscience 2008, 151:1099-1103.
299. Roberge M.C., Hotte-Bernard J., Messier C., Plamondon H. Food restriction attenuates ischemia-induced spatial learning and memory deficits despite extensive CA1 ischemic injury. Behav. Brain Res. 2008, 187:123-132.
300. Rosenzweig H.L., Lessov N.S., Henshall D.C., Minami M., Simon R.P., Stenzel-Poore M.P. Endotoxin preconditioning prevents cellular inflammatory response during ischemic neuroprotection in mice. Stroke 2004, 35:2576-2581.
301. Rosenzweig H.L., Minami M., Lessov N.S., Coste S.C., Stevens S.L., Henshall D.C., Meller R., Simon R.P., Stenzel-Poore M.P. Endotoxin preconditioning protects against the cytotoxic effects of TNFalpha after stroke: a novel role for TNFalpha in LPS-ischemic tolerance. J. Cereb. Blood Flow Metab. 2007, 27:1663-1674.
302. Ross G.W., Petrovitch H. Current evidence for neuroprotective effects of nicotine and caffeine against Parkinson's disease. Drugs Aging 2001, 18:797-806.
303. Sakata H., Narasimhan P., Niizuma K., Maier C.M., Wakai T., Chan P.H. Interleukin 6-preconditioned neural stem cells reduce ischaemic injury in stroke mice. Brain 2012, 135:3298-3310.
304. Sakata H., Niizuma K., Yoshioka H., Kim G.S., Jung J.E., Katsu M., Narasimhan P., Maier C.M., Nishiyama Y., Chan P.H. Minocycline-preconditioned neural stem cells enhance neuroprotection after ischemic stroke in rats. J. Neurosci. 2012, 32:3462-3473.
305. Saklani R., Jaggi A., Singh N. Pharmacological preconditioning by milrinone: memory preserving and neuroprotective effect in ischemia-reperfusion injury in mice. Arch. Pharm. Res. 2010, 33:1049-1057.
306. Saleh M.C., Connell B.J., Saleh T.M. Ischemic tolerance following low dose NMDA involves modulation of cellular stress proteins. Brain Res. 2009, 1247:212-220.
307. Sasaoka N., Kawaguchi M., Kawaraguchi Y., Nakamura M., Konishi N., Patel H., Patel P.M., Furuya H. Isoflurane exerts a short-term but not a long-term preconditioning effect in neonatal rats exposed to a hypoxic-ischaemic neuronal injury. Acta Anaesthesiol. Scand. 2009, 53:46-54.
308. Schroeder J.E., Richardson J.C., Virley D.J. Dietary manipulation and caloric restriction in the development of mouse models relevant to neurological diseases. Biochim. Biophys. Acta 2010, 1802:840-846.
309. Shankaran M., Gudelsky G.A. Effect of 3,4-methylenedioxymethamphetamine (MDMA) on hippocampal dopamine and serotonin. Pharmacol. Biochem. Behav. 1998, 61:361-366.
310. Shein N.A., Horowitz M., Shohami E. Heat acclimation: a unique model of physiologically mediated global preconditioning against traumatic brain injury. Prog. Brain Res. 2007, 161:353-363.
311. Sigaut S., Jannier V., Rouelle D., Gressens P., Mantz J., Dahmani S. The preconditioning effect of sevoflurane on the oxygen glucose-deprived hippocampal slice: the role of tyrosine kinases and duration of ischemia. Anesth. Analg. 2009, 108:601-608.
312. Silachev D.N., Isaev N.K., Pevzner I.B., Zorova L.D., Stelmashook E.V., Novikova S.V., Plotnikov E.Y., Skulachev V.P., Zorov D.B. The mitochondria-targeted antioxidants and remote kidney preconditioning ameliorate brain damage through kidney-to-brain cross-talk. PLoS ONE 2012, 7:e51553.
313. Singh A.K., Jiang Y., Gupta S., Benlhabib E. Effects of chronic ethanol drinking on the blood brain barrier and ensuing neuronal toxicity in alcohol-preferring rats subjected to intraperitoneal LPS injection. Alcohol Alcohol. 2007, 42:385-399.
314. Singh N., Agrawal M., Dore S. Neuroprotective properties and mechanisms of resveratrol in in vitro and in vivo experimental cerebral stroke models. ACS Chem. Neurosci. 2013, 4:1151-1162.
315. Soejima Y., Ostrowski R.P., Manaenko A., Fujii M., Tang J., Zhang J.H. Hyperbaric oxygen preconditioning attenuates hyperglycemia enhanced hemorrhagic transformation after transient MCAO in rats. Med. Gas Res. 2012, 2:9.
316. Sommer C. Ischemic preconditioning: postischemic structural changes in the brain. J. Neuropathol. Exp. Neurol. 2008, 67:85-92.
317. Speelman A.D., van de Warrenburg B.P., van Nimwegen M., Petzinger G.M., Munneke M., Bloem B.R. How might physical activity benefit patients with Parkinson disease?. Nat. Rev. Neurol. 2011, 7:528-534.
318. Speetzen, L.J., Endres, M., Kunz, A., 2013. Bilateral common carotid artery occlusion as an adequate preconditioning stimulus to induce early ischemic tolerance to focal cerebral ischemia. J. Vis. Exp.
319. Stagliano N.E., Perez-Pinzon M.A., Moskowitz M.A., Huang P.L. Focal ischemic preconditioning induces rapid tolerance to middle cerebral artery occlusion in mice. J. Cereb. Blood Flow Metab. 1999, 19:757-761.
320. Stampfer M.J., Colditz G.A., Willett W.C., Speizer F.E., Hennekens C.H. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N. Engl. J. Med. 1988, 319:267-273.
321. Stevens S.L., Ciesielski T.M., Marsh B.J., Yang T., Homen D.S., Boule J.L., Lessov N.S., Simon R.P., Stenzel-Poore M.P. Toll-like receptor 9: a new target of ischemic preconditioning in the brain. J. Cereb. Blood Flow Metab. 2008, 28:1040-1047.
322. Su Z., Han D., Sun B., Qiu J., Li Y., Li M., Zhang T., Yang Z. Heat stress preconditioning improves cognitive outcome after diffuse axonal injury in rats. J. Neurotrauma 2009, 26:1695-1706.
323. Sugino T., Nozaki K., Takagi Y., Hashimoto N. 3-Nitropropionic acid induces ischemic tolerance in gerbil hippocampus in vivo. Neurosci. Lett. 1999, 259:9-12.
324. Sun L., Zhou W., Heiland S., Marti H.H., Veltkamp R. A translationally relevant thromboembolic stroke model for the study of secondary hemorrhage after thrombolysis in rats. Brain Res. 2011, 1368:346-354.
325. Suzuki Y., Kim H.W., Ashraf M., Haider H. Diazoxide potentiates mesenchymal stem cell survival via NF-kappaB-dependent miR-146a expression by targeting Fas. Am. J. Physiol. Heart Circ. Physiol. 2010, 299:H1077-H1082.
326. Taga K., Patel P.M., Drummond J.C., Cole D.J., Kelly P.J. Transient neuronal depolarization induces tolerance to subsequent forebrain ischemia in rats. Anesthesiology 1997, 87:918-925.
327. Tai K.K., Truong D.D. Activation of adenosine triphosphate-sensitive potassium channels confers protection against rotenone-induced cell death: therapeutic implications for Parkinson's disease. J. Neurosci. Res. 2002, 69:559-566.
328. Takagi H., Manabe H., Kawai N., Goto S.N., Umemoto T. Review and meta-analysis of randomized controlled clinical trials of remote ischemic preconditioning in cardiovascular surgery. Am. J. Cardiol. 2008, 102:1487-1488.
329. Tanay E., Mundel P., Sommer C. Short-term ischemia usually used for ischemic preconditioning causes loss of dendritic integrity after long-term survival in the gerbil hippocampus. Brain Res. 2006, 1112:222-226.
330. Tang J.X., Mardini F., Caltagarone B.M., Garrity S.T., Li R.Q., Bianchi S.L., Gomes O., Laferla F.M., Eckenhoff R.G., Eckenhoff M.F. Anesthesia in presymptomatic Alzheimer's disease: a study using the triple-transgenic mouse model. Alzheimers Dement. 2011, 7:521-531.
331. Tang S.C., Arumugam T.V., Xu X., Cheng A., Mughal M.R., Jo D.G., Lathia J.D., Siler D.A., Chigurupati S., Ouyang X., Magnus T., Camandola S., Mattson M.P. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:13798-13803.
332. 2 in PC12 cells: mechanisms via MMP, ROS, and Bcl-2. Brain Res. 2005, 1057:57-64.
333. Tang Y., Pacary E., Freret T., Divoux D., Petit E., Schumann-Bard P., Bernaudin M. Effect of hypoxic preconditioning on brain genomic response before and following ischemia in the adult mouse: identification of potential neuroprotective candidates for stroke. Neurobiol. Dis. 2006, 21:18-28.
334. Tasaki K., Ruetzler C.A., Ohtsuki T., Martin D., Nawashiro H., Hallenbeck J.M. Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Res. 1997, 748:267-270.
335. Texel S.J., Mattson M.P. Impaired adaptive cellular responses to oxidative stress and the pathogenesis of Alzheimer's disease. Antioxid. Redox Signal. 2011, 14:1519-1534.
336. Tillerson J.L., Cohen A.D., Caudle W.M., Zigmond M.J., Schallert T., Miller G.W. Forced nonuse in unilateral parkinsonian rats exacerbates injury. J. Neurosci. 2002, 22:6790-6799.
337. Tillerson J.L., Cohen A.D., Philhower J., Miller G.W., Zigmond M.J., Schallert T. Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine. J. Neurosci. 2001, 21:4427-4435.
338. Tissenbaum H.A., Ruvkun G. An insulin-like signaling pathway affects both longevity and reproduction in Caenorhabditis elegans. Genetics 1998, 148:703-717.
339. Tu Y.F., Lu P.J., Huang C.C., Ho C.J., Chou Y.P. Moderate dietary restriction reduces p53-mediated neurovascular damage and microglia activation after hypoxic ischemia in neonatal brain. Stroke 2012, 43:491-498.
340. Turrens J.F. Mitochondrial formation of reactive oxygen species. J. Physiol. 2003, 552:335-344.
341. Umschweif G., Alexandrovich A.G., Trembovler V., Horowitz M., Shohami E. Hypoxia-inducible factor 1 is essential for spontaneous recovery from traumatic brain injury and is a key mediator of heat acclimation induced neuroprotection. J. Cereb. Blood Flow Metab. 2013, 33:524-531.
342. Umschwief G., Shein N.A., Alexandrovich A.G., Trembovler V., Horowitz M., Shohami E. Heat acclimation provides sustained improvement in functional recovery and attenuates apoptosis after traumatic brain injury. J. Cereb. Blood Flow Metab. 2010, 30:616-627.
343. van Hamersvelt H.W., Kloke H.J., de Jong D.J., Koene R.A., Huysmans F.T. Oedema formation with the vasodilators nifedipine and diazoxide: direct local effect or sodium retention?. J. Hypertens 1996, 14:1041-1045.
344. Vance R.E., Isberg R.R., Portnoy D.A. Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system. Cell Host Microbe 2009, 6:10-21.
345. Vannucci R.C., Vannucci S.J. A model of perinatal hypoxic-ischemic brain damage. Ann. N. Y. Acad. Sci. 1997, 835:234-249.
346. Vannucci S.J., Hagberg H. Hypoxia-ischemia in the immature brain. J. Exp. Biol. 2004, 207:3149-3154.
347. Vaughan P.J., Pike C.J., Cotman C.W., Cunningham D.D. Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults. J. Neurosci. 1995, 15:5389-5401.
348. Velly L.J., Canas P.T., Guillet B.A., Labrande C.N., Masmejean F.M., Nieoullon A.L., Gouin F.M., Bruder N.J., Pisano P.S. Early anesthetic preconditioning in mixed cortical neuronal-glial cell cultures subjected to oxygen-glucose deprivation: the role of adenosine triphosphate dependent potassium channels and reactive oxygen species in sevoflurane-induced neuroprotection. Anesth. Analg. 2009, 108:955-963.
349. Wacker B.K., Park T.S., Gidday J.M. Hypoxic preconditioning-induced cerebral ischemic tolerance: role of microvascular sphingosine kinase 2. Stroke 2009, 40:3342-3348.
350. Wada K., Ito M., Miyazawa T., Katoh H., Nawashiro H., Shima K., Chigasaki H. Repeated hyperbaric oxygen induces ischemic tolerance in gerbil hippocampus. Brain Res. 1996, 740:15-20.
351. Wada, K., Miyazawa, T., Nomura, N., Tsuzuki, N., Nawashiro, H., Shima, K., 2001. Preferential conditions for and possible mechanisms of induction of ischemic tolerance by repeated hyperbaric oxygenation in gerbil hippocampus. Neurosurgery 49, 160-166 (discussion 166-167).
352. Walsh S.R., Nouraei S.A., Tang T.Y., Sadat U., Carpenter R.H., Gaunt M.E. Remote ischemic preconditioning for cerebral and cardiac protection during carotid endarterectomy: results from a pilot randomized clinical trial. Vasc. Endovasc. Surg. 2010, 44:434-439.
353. Walsh S.R., Tang T.Y., Kullar P., Jenkins D.P., Dutka D.P., Gaunt M.E. Ischaemic preconditioning during cardiac surgery: systematic review and meta-analysis of perioperative outcomes in randomised clinical trials. Eur. J. Cardiothorac. Surg. 2008, 34:985-994.
354. Wang H., Luo M., Li C., Wang G. Propofol post-conditioning induced long-term neuroprotection and reduced internalization of AMPAR GluR2 subunit in a rat model of focal cerebral ischemia/reperfusion. J. Neurochem. 2011, 119:210-219.
355. Wang L., Zhu Q.L., Wang G.Z., Deng T.Z., Chen R., Liu M.H., Wang S.W. The protective roles of mitochondrial ATP-sensitive potassium channels during hypoxia-ischemia-reperfusion in brain. Neurosci. Lett. 2011, 491:63-67.
356. Wang J., Ho L., Qin W., Rocher A.B., Seror I., Humala N., Maniar K., Dolios G., Wang R., Hof P.R., Pasinetti G.M. Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease. FASEB J. 2005, 19:659-661.
357. Wang J., Lei B., Popp S., Meng F., Cottrell J.E., Kass I.S. Sevoflurane immediate preconditioning alters hypoxic membrane potential changes in rat hippocampal slices and improves recovery of CA1 pyramidal cells after hypoxia and global cerebral ischemia. Neuroscience 2007, 145:1097-1107.
358. Wang Q., Sun A.Y., Simonyi A., Kalogeris T.J., Miller D.K., Sun G.Y., Korthuis R.J. Ethanol preconditioning protects against ischemia/reperfusion-induced brain damage: role of NADPH oxidase-derived ROS. Free Radic. Biol. Med. 2007, 43:1048-1060.
359. Wang J.K., Yu L.N., Zhang F.J., Yang M.J., Yu J., Yan M., Chen G. Postconditioning with sevoflurane protects against focal cerebral ischemia and reperfusion injury via PI3K/Akt pathway. Brain Res. 2010, 1357:142-151.
360. + channels. Microcirculation 2010, 17:427-438.
361. Wang S., Yan J.Y., Lo Y.K., Carvey P.M., Ling Z. Dopaminergic and serotoninergic deficiencies in young adult rats prenatally exposed to the bacterial lipopolysaccharide. Brain Res. 2009, 1265:196-204.
362. Wang W.Z., Jones S., Stepheson L.L., Khiabani K.T., Zamboni W.A. Microvascular protection induced by late preconditioning was abolished in STZ-induced acute diabetic rats. J. Reconstr. Microsurg. 2002, 18:689-696.
363. Warner D.S., McFarlane C., Todd M.M., Ludwig P., McAllister A.M. Sevoflurane and halothane reduce focal ischemic brain damage in the rat. Possible influence on thermoregulation. Anesthesiology 1993, 79:985-992.
364. Wegelius K., Korpi E.R. Ethanol inhibits NMDA-induced toxicity and trophism in cultured cerebellar granule cells. Acta Physiol. Scand. 1995, 154:25-34.
365. Wegener S., Gottschalk B., Jovanovic V., Knab R., Fiebach J.B., Schellinger P.D., Kucinski T., Jungehulsing G.J., Brunecker P., Muller B., Banasik A., Amberger N., Wernecke K.D., Siebler M., Rother J., Villringer A., Weih M. Transient ischemic attacks before ischemic stroke: preconditioning the human brain?. A multicenter magnetic resonance imaging study. Stroke 2004, 35:616-621.
366. Wei D., Ren C., Chen X., Zhao H. The chronic protective effects of limb remote preconditioning and the underlying mechanisms involved in inflammatory factors in rat stroke. PLoS ONE 2012, 7:e30892.
367. Wei L., Fraser J.L., Lu Z.Y., Hu X., Yu S.P. Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats. Neurobiol. Dis. 2012, 46:635-645.
368. Wei N., Yu S.P., Gu X., Taylor T.M., Song D., Liu X.F., Wei L. Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice. Cell Transplant. 2013, 22:977-991.
369. Weih M., Kallenberg K., Bergk A., Dirnagl U., Harms L., Wernecke K.D., Einhaupl K.M. Attenuated stroke severity after prodromal TIA: a role for ischemic tolerance in the brain?. Stroke 1999, 30:1851-1854.
370. Werner C., Mollenberg O., Kochs E., Schulte J.a.E. Sevoflurane improves neurological outcome after incomplete cerebral ischaemia in rats. Br. J. Anaesth. 1995, 75:756-760.
371. Whitham M., Fortes M.B. Heat shock protein 72: release and biological significance during exercise. Front. Biosci. 2008, 13:1328-1339.
372. Wu C., Zhan R.Z., Qi S., Fujihara H., Taga K., Shimoji K. A forebrain ischemic preconditioning model established in C57Black/Crj6 mice. J. Neurosci. Methods 2001, 107:101-106.
373. Wu P., Jiang C., Shen Q., Hu Y. Systematic gene expression profile of hypothalamus in calorie-restricted mice implicates the involvement of mTOR signaling in neuroprotective activity. Mech. Ageing Dev. 2009, 130:602-610.
374. Wu P., Shen Q., Dong S., Xu Z., Tsien J.Z., Hu Y. Calorie restriction ameliorates neurodegenerative phenotypes in forebrain-specific presenilin-1 and presenilin-2 double knockout mice. Neurobiol. Aging 2008, 29:1502-1511.
375. Wu S.Y., Wang T.F., Yu L., Jen C.J., Chuang J.I., Wu F.S., Wu C.W., Kuo Y.M. Running exercise protects the substantia nigra dopaminergic neurons against inflammation-induced degeneration via the activation of BDNF signaling pathway. Brain Behav. Immun. 2011, 25:135-146.
376. Xi G., Keep R.F., Hua Y., Xiang J., Hoff J.T. Attenuation of thrombin-induced brain edema by cerebral thrombin preconditioning. Stroke 1999, 30:1247-1255.
377. Xiao F., Fratkin J.D., Rhodes P.G., Cai Z. Reduced nitric oxide is involved in prenatal ischemia-induced tolerance to neonatal hypoxic-ischemic brain injury in rats. Neurosci. Lett. 2000, 285:5-8.
378. Xiong L., Zheng Y., Wu M., Hou L., Zhu Z., Zhang X., Lu Z. Preconditioning with isoflurane produces dose-dependent neuroprotection via activation of adenosine triphosphate-regulated potassium channels after focal cerebral ischemia in rats. Anesth. Analg. 2003, 96:233-237.
379. Xu H., Aibiki M., Nagoya J. Neuroprotective effects of hyperthermic preconditioning on infarcted volume after middle cerebral artery occlusion in rats: role of adenosine receptors. Crit. Care Med. 2002, 30:1126-1130.
380. Xu K., Sun X., Puchowicz M.A., LaManna J.C. Increased sensitivity to transient global ischemia in aging rat brain. Adv. Exp. Med. Biol. 2007, 599:199-206.
381. Xu Q., Park Y., Huang X., Hollenbeck A., Blair A., Schatzkin A., Chen H. Physical activities and future risk of Parkinson disease. Neurology 2010, 75:341-348.
382. Yang H., Hreggvidsdottir H.S., Palmblad K., Wang H., Ochani M., Li J., Lu B., Chavan S., Rosas-Ballina M., Al-Abed Y., Akira S., Bierhaus A., Erlandsson-Harris H., Andersson U., Tracey K.J. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:11942-11947.
383. Yang Q.W., Xiang J., Zhou Y., Zhong Q., Li J.C. Targeting HMGB1/TLR4 signaling as a novel approach to treatment of cerebral ischemia. Front. Biosci. (Scholar Ed.) 2010, 2:1081-1091.
384. Yannopoulos F.S., Makela T., Niemela E., Tuominen H., Lepola P., Alestalo K., Kaakinen H., Kiviluoma K., Anttila V., Juvonen T. Improved cerebral recovery from hypothermic circulatory arrest after remote ischemic preconditioning. Ann. Thorac. Surg. 2010, 90:182-188.
385. Yao Q.L., Zhang M.F., Wang C.H., Hu F., Lan A.P., Guo R.X., Chen P.X., Feng J.Q. Protective effects of early hypoxic post-conditioning in cultured cortical neurons. Brain Inj. 2011, 25:604-613.
386. Ye R., Yang Q., Kong X., Li N., Zhang Y., Han J., Xiong L., Liu X., Zhao G. Sevoflurane preconditioning improves mitochondrial function and long-term neurologic sequelae after transient cerebral ischemia: role of mitochondrial permeability transition. Crit. Care Med. 2012, 40:2685-2693.
387. Ye Z., Guo Q., Wang N., Xia P., Yuan Y., Wang E. Delayed neuroprotection induced by sevoflurane via opening mitochondrial ATP-sensitive potassium channels and p38 MAPK phosphorylation. Neurol. Sci. 2012, 33:239-249.
388. Yu J.T., Lee C.H., Yoo K.Y., Choi J.H., Li H., Park O.K., Yan B., Hwang I.K., Kwon Y.G., Kim Y.M., Won M.H. Maintenance of anti-inflammatory cytokines and reduction of glial activation in the ischemic hippocampal CA1 region preconditioned with lipopolysaccharide. J. Neurol. Sci. 2010, 296:69-78.
389. Yu Z.F., Mattson M.P. Dietary restriction and 2-deoxyglucose administration reduce focal ischemic brain damage and improve behavioral outcome: evidence for a preconditioning mechanism. J. Neurosci. Res. 1999, 57:830-839.
390. Yuan H.B., Huang Y., Zheng S., Zuo Z. Hypothermic preconditioning increases survival of purkinje neurons in rat cerebellar slices after an in vitro simulated ischemia. Anesthesiology 2004, 100:331-337.
391. Yuan H.B., Huang Y., Zheng S., Zuo Z. Hypothermic preconditioning reduces Purkinje cell death possibly by preventing the over-expression of inducible nitric oxide synthase in rat cerebellar slices after an in vitro simulated ischemia. Neuroscience 2006, 142:381-389.
392. Yunoki M., Nishio S., Ukita N., Anzivino M.J., Lee K.S. Characteristics of hypothermic preconditioning influencing the induction of delayed ischemic tolerance. J. Neurosurg. 2002, 97:650-657.
393. Yurkewicz L., Weaver J., Bullock M.R., Marshall L.F. The effect of the selective NMDA receptor antagonist traxoprodil in the treatment of traumatic brain injury. J. Neurotrauma 2005, 22:1428-1443.
394. Zhan L., Wang T., Li W., Xu Z.C., Sun W., Xu E. Activation of Akt/FoxO signaling pathway contributes to induction of neuroprotection against transient global cerebral ischemia by hypoxic pre-conditioning in adult rats. J. Neurochem. 2010, 114:897-908.
395. Zhang H.P., Yuan L.B., Zhao R.N., Tong L., Ma R., Dong H.L., Xiong L. Isoflurane preconditioning induces neuroprotection by attenuating ubiquitin-conjugated protein aggregation in a mouse model of transient global cerebral ischemia. Anesth. Analg. 2010, 111:506-514.
396. Zhang J., Qian H., Zhao P., Hong S.S., Xia Y. Rapid hypoxia preconditioning protects cortical neurons from glutamate toxicity through delta-opioid receptor. Stroke 2006, 37:1094-1099.
397. Zhang W., Wang B., Zhou S., Qiu Y. The effect of ischemic post-conditioning on hippocampal cell apoptosis following global brain ischemia in rats. J. Clin. Neurosci. 2012, 19:570-573.
398. Zhang Y., Park T.S., Gidday J.M. Hypoxic preconditioning protects human brain endothelium from ischemic apoptosis by Akt-dependent survivin activation. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H2573-H2581.
399. Zhao H. Ischemic postconditioning as a novel avenue to protect against brain injury after stroke. J. Cereb. Blood Flow Metab. 2009, 29:873-885.
400. Zhao H., Ren C., Chen X., Shen J. From rapid to delayed and remote postconditioning: the evolving concept of ischemic postconditioning in brain ischemia. Curr. Drug Targets 2012, 13:173-187.
401. Zhao H., Sapolsky R.M., Steinberg G.K. Interrupting reperfusion as a stroke therapy: ischemic postconditioning reduces infarct size after focal ischemia in rats. J. Cereb. Blood Flow Metab. 2006, 26:1114-1121.
402. Zhao P., Huang Y., Zuo D Z. Opioid preconditioning induces opioid receptor-dependent delayed neuroprotection against ischemia in rats. J. Neuropathol. Exp. Neurol. 2006, 65:945-952.
403. Zhao P., Peng L., Li L., Xu X., Zuo Z. Isoflurane preconditioning improves long-term neurologic outcome after hypoxic-ischemic brain injury in neonatal rats. Anesthesiology 2007, 107:963-970.
404. Zhao P., Zuo Z. Isoflurane preconditioning induces neuroprotection that is inducible nitric oxide synthase-dependent in neonatal rats. Anesthesiology 2004, 101:695-703.
405. Zheng S., Zuo Z. Isoflurane preconditioning induces neuroprotection against ischemia via activation of P38 mitogen-activated protein kinases. Mol Pharmacol 2004, 65:1172-1180.
406. Zhou A.M., Li W.B., Li Q.J., Liu H.Q., Feng R.F., Zhao H.G. A short cerebral ischemic preconditioning up-regulates adenosine receptors in the hippocampal CA1 region of rats. Neurosci. Res. 2004, 48:397-404.
407. Zhou C., Tu J., Zhang Q., Lu D., Zhu Y., Zhang W., Yang F., Brann D.W., Wang R. Delayed ischemic postconditioning protects hippocampal CA1 neurons by preserving mitochondrial integrity via Akt/GSK3beta signaling. Neurochem. Int. 2011, 59:749-758.
408. Zhou Y., Fathali N., Lekic T., Ostrowski R.P., Chen C., Martin R.D., Tang J., Zhang J.H. Remote limb ischemic postconditioning protects against neonatal hypoxic-ischemic brain injury in rat pups by the opioid receptor/Akt pathway. Stroke 2011, 42:439-444.
409. Zhu D., Wu X., Strauss K.I., Lipsky R.H., Qureshi Z., Terhakopian A., Novelli A., Banaudha K., Marini A.M. N-methyl-d-aspartate and TrkB receptors protect neurons against glutamate excitotoxicity through an extracellular signal-regulated kinase pathway. J. Neurosci. Res. 2005, 80:104-113.
410. Zhu H., Guo Q., Mattson M.P. Dietary restriction protects hippocampal neurons against the death-promoting action of a presenilin-1 mutation. Brain Res. 1999, 842:224-229.
411. Zhu H.C., Gao X.Q., Xing Y., Sun S.G., Li H.G., Wang Y.F. Inhibition of caspase-3 activation and apoptosis is involved in 3-nitropropionic acid-induced ischemic tolerance to transient focal cerebral ischemia in rats. J. Mol. Neurosci. 2004, 24:299-305.
412. Zhu W., Wang L., Zhang L., Palmateer J.M., Libal N.L., Hurn P.D., Herson P.S., Murphy S.J. Isoflurane preconditioning neuroprotection in experimental focal stroke is androgen-dependent in male mice. Neuroscience 2010, 169:758-769.
413. Ziegler G., Harhausen D., Schepers C., Hoffmann O., Rohr C., Prinz V., Konig J., Lehrach H., Nietfeld W., Trendelenburg G. TLR2 has a detrimental role in mouse transient focal cerebral ischemia. Biochem. Biophys. Res. Commun. 2007, 359:574-579.
414. Zigmond M.J., Cameron J.L., Hoffer B.J., Smeyne R.J. Neurorestoration by physical exercise: moving forward. Parkinsonism Relat. Disord. 2012, 18(Suppl. 1):S147-S150.
415. Zigmond M.J., Cameron J.L., Leak R.K., Mirnics K., Russell V.A., Smeyne R.J., Smith A.D. Triggering endogenous neuroprotective processes through exercise in models of dopamine deficiency. Parkinsonism Relat. Disord. 2009, 15(Suppl. 3):S42-S45.